Skip to main content

Table 2 Incidence and severity of postoperative Sore Throat

From: The effect of preoperative topical magnesium sulfate spraying in the oropharyngeal region on postoperative sore throat following gynecological laparoscopic surgery: a randomized clinical trial

Variables

Control Group (n = 29)

Magnesium Group (n = 29)

χ²/Z

p

Sore throat

    

Overall incidence

20(66.7%)

6(20.0%)

13.303

< 0.001a

0 h postoperatively(T1)

18(60.0%)

4(13.3%)

14.067

< 0.001a

2 h postoperatively(T2)

12(40.0%)

4(13.3%)

5.455

0.02a

6 h postoperatively(T3)

11(36.7%)

3(10.0%)

5.963

0.015a

12 h postoperatively(T4)

8(26.7%)

3(10.0%)

2.783

0.095

24 h postoperatively(T5)

4(13.3%)

2(6.7%)

0.185

0.667

48 h postoperatively(T6)

3(10.0%)

2(6.7%)

0.000

1.000

NRS of sore throatb

    

0 h postoperatively(T1)

1(0–2)

0(0–0)

−3.822

< 0.001a

2 h postoperatively(T2)

0(0–1)

0(0–0)

−2.448

0.014a

6 h postoperatively(T3)

0(0–1)c

0(0–1)

−2.497

0.013a

12 h postoperatively(T4)

0(0–0)c

0(0–0)

−1.684

0.092

24 h postoperatively(T5)

0(0–0)c

0(0–0)

−0.881

0.378

48 h postoperatively(T6)

0(0–0)c

0(0–0)

−0.524

0.600

  1. a Compared Magnesium Group with Control Group, P < 0.05
  2. b NRS of sore throat were compared in generalized estimating equations between and within groups (P for group < 0.001, P for time < 0.001, P for interaction = 0.019; Waldχ² for groups = 11.514, Waldχ² for time = 20.016, Waldχ² for interaction = 13.534)
  3. cP < 0.05 for each time point vs. T1 within Magnesium group